Standard Biotools Inc. (lab 2.75 02/01/34)
13F holders, Q4 2024 (December 31)3holders +1
1new positions
0sold out
$21.59avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Standard Biotools Inc. (lab 2.75 02/01/34) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Kestra Advisory Services, LLC ($791K), Envestnet Asset Management Inc. ($20K) and Mariner, LLC ($10K).
- Company
- Standard Biotools Inc. (lab 2.75 02/01/34)
- CUSIP
- 34385PAA6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $791K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 8,000 shares bought, net +8,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Kestra Advisory Services, LLC | 0.00% | New | 8,000 | $791K |
| Envestnet Asset Management Inc. | 0.00% | No change | 20,000 | $20K |
| Mariner, LLC | 0.00% | No change | 10,000 | $10K |
"% of holder's portfolio" is STANDARD BIOTOOLS INC (LAB 2.75 02/01/34)'s weight in each manager's 13F, not the share of Standard Biotools Inc. (lab 2.75 02/01/34) the manager owns.